We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Cardiology

Journal Scan / Research · June 12, 2019

Lisinopril vs Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast Cancer

Journal of the American College of Cardiology

 

Additional Info

Disclosure statements are available on the authors' profiles:

Journal of the American College of Cardiology
Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast Cancer
J Am Coll Cardiol 2019 Jun 11;73(22)2859-2868, M Guglin, J Krischer, R Tamura, A Fink, L Bello-Matricaria, W McCaskill-Stevens, PN Munster

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading